The influence of opioids and nonopioid central nervous system active medications on central sleep apnea: a case-control study | Zendy

Ronald Gavidia | Zendy; Amara Emenike | Zendy; Anran Meng | Zendy; Erica C. Jansen | Zendy; Shelley Hershner | Zendy; Cathy Goldstein | Zendy; Judy Fetterolf | Zendy; Galit Levi Dunietz | Zendy

Open Access

The influence of opioids and nonopioid central nervous system active medications on central sleep apnea: a case-control study

Author(s) -

Ronald Gavidia,

Amara Emenike,

Anran Meng,

Erica C. Jansen,

Shelley Hershner,

Cathy Goldstein,

Judy Fetterolf,

Galit Levi Dunietz

Publication year - 2020

Publication title -

journal of clinical sleep medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.529

H-Index - 92

eISSN - 1550-9397

pISSN - 1550-9389

DOI - 10.5664/jcsm.8826

Subject(s) - medicine , polysomnography , odds ratio , apnea , anesthesia , logistic regression , odds , central sleep apnea , opioid , sleep apnea , pediatrics , receptor

Opioids are known to contribute to central sleep apnea (CSA), but the influence of nonopioid central nervous system active medications (CNSAMs) on CSA remains unclear. In light of the hypothesized impact of nonopioid CNSAMs on respiration, we examined the relationships between the use of opioids only, nonopioid CNSAMs alone, and their combination with CSA.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research